National Advisory Council Agenda

143rd Meeting of the National Advisory Council on Drug Abuse

Virtual Meeting – February 8, 2023

Closed Session

This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2). 

Time Presentation
11:00 a.m. Call to Order
Nora Volkow, M.D.
Director, NIDA

Review of Policy and Procedures
Susan Weiss, Ph.D.
Executive Secretary
National Advisory Council on Drug Abuse
Director, Division of Extramural Research, NIDA
11:15 a.m.

Council Review of Grant Applications
Nora Volkow, M.D., Director, NIDA

Office of Research Training, Diversity, and Disparities (ORTDD)
Aria Crump, Sc.D., Deputy Director, ORTDD

Division of Epidemiology, Services, and Prevention Research (DESPR)
Carlos Blanco, M.D., Ph.D., Director

Office of Translational Initiatives and Program Innovationa (OTIPI)
Elena Koustova, Ph.D., M.B.A., Director

Division of Therapeutics and Medical Consequences (DTMC)
Iván Montoya, M.D., M.P.H., Acting Director

Division of Neuroscience and Behavior (DNB)
Rita Valentino, Ph.D., Director

Brief Break
12:15 p.m. Report to Council from the Board of Scientific Counselors (BSC)
Amy Newman, Ph.D., Director, NIDA IRP; John Mantsch, Ph.D., BSC Chair
12:45 p.m. Break

Videocast:

Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Gillian Acca, within ten days of the meeting.  Any written statements by members of the public will receive careful consideration.

Join the Videocast

Open Session

Time Presentation
1:15 p.m. Welcome and Opening Remarks
Nora Volkow, M.D., Director, NIDA
1:30 p.m. Director's Report
Nora Volkow, M.D., Director, NIDA
2:20 p.m. Discussion
Council Members
2:45 p.m. What’s HOT at the NIDA-IRP
Amy Newman, Ph.D., Director, NIDA IRP
3:15 p.m. Break
3:30 p.m. MERIT Award Discussion
Susan Weiss, Ph.D.
Director, Division of Extramural Research, NIDA
4:00 p.m. Medications Development Council Workgroup Report
Iván Montoya, M.D., M.P.H.
Acting Director, DTMC
4:15 p.m.

Concept Clearances​

  • Office of Research Training, Diversity, and Disparities (ORTDD)
    • NIDA Research Education Program for Clinical Researchers and Clinicians – Aria Crump, Sc.D., Deputy Director
  • Division of Epidemiology, Services, and Prevention Research (DESPR)
    • National Addiction & HIV Data Archive Program (NAHDAP) – Janet Kuramoto-Crawford, Ph.D., M.H.S., Social Behavioral Scientist Administrator
    • American Indian and Alaska Native Collective Research Effort to Enhance Wellness (AI/AN CREW): Addressing Opioid/Drug Misuse, Mental Health and Pain – Kathy Etz, Ph.D., Director of Native American Programs
    • Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services – Minnjuan Flournoy Floyd, Ph.D., Health Scientist Administrator
    • Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services – Minnjuan Flournoy Floyd, Ph.D., Health Scientist Administrator
    • Addressing HIV in Highest Risk Sexual and Gender Minorities – Richard Jenkins, Ph.D., Health Scientist Administrator
    • Cohort Studies of HIV/AIDS and Substance Use – Sheba Dunston, Ed.D., M.P.H., CHES, Social Behavioral Scientist Administrator
    • Research to Address SUD in the Criminal-Legal System – Tisha Wiley, Ph.D., Chief, Services Research Branch
    • Research to Increase Implementation of Substance Use Preventive Services – Amy Goldstein, Ph.D., Chief, Prevention Research Branch
    • Resource Networks to Advance the Impact of Addiction Services Research through Researcher/Decision Maker Collaborations – Sarah Duffy, Ph.D., Associate Director for Economics Research
  • Division of Therapeutics and Medical Consequences (DTMC)
    • Development of Clinical Outcome Assessments as New FDA-Qualified Drug Development Tools for Opioid and Stimulant Use Disorders to Accelerate Therapeutic Development – Tanya Ramey, M.D., Ph.D., Medical Officer
    Division of Neuroscience and Behavior (DNB)
    • ex vivo Models for Studies at the Intersection of HIV and Poly-Substance Use – Da-Yu Wu, Ph.D., Health Scientist Administrator
    • Mechanistic Studies on the Effects of Psychosocial Stress in Complex Morbidity Involving SUD/s, Psychiatric Disorders, and HIV – Sunila Nair, Ph.D., Health Scientist Administrator
    • Effects of HIV and Substance Use Comorbidity on the Placenta – Sunila Nair, Ph.D., Health Scientist Administrator
    • Interplay of Autophagy Regulated Cell Death and HIV Pathogenesis in Substance Use Disorders – Anne Tsai, Ph.D., Health Scientist Administrator
    • Targeting Inflammasomes in Substance Use and HIV –  Anne Tsai, Ph.D., Health Scientist Administrator
    • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use – Kiran Vemuri, Ph.D., Health Scientist Administrator
    • Chemical Probes and Drugs for Modulating HIV Transcription in People with Substance Use Disorders – Sam Ananthan, Ph.D., Branch Chief, Chemistry and Pharmacology
    • Microglial Pathophysiology in Comorbid HIV and SUD – Tristan McClure-Begley, Ph.D., Branch Chief, Integrative Neuroscience
    • SCORCH (Single Cell Opioid Responses in the Context of HIV) Program: Data Coordination, Analysis, and Scientific Outreach – John Satterlee, Ph.D., Health Scientist Administrator
    • SCORCH (Single Cell Opioid Responses in the Context of HIV) Program: Data Mining and Functional Validation – John Satterlee, Ph.D., Health Scientist Administrator
  • Division of Extramural Research (DER)
    • ABCD Study® Data Sharing Platform – Elizabeth Hoffman, Ph.D., Health Scientist Administrator
4:45 p.m. Public Comments
5:00 p.m. Adjourn